NCT01029522View on ClinicalTrials.gov

Dyslipidemia in Cardiovascular Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2009

Conditions
Dyslipidemia
Interventions
DRUG

Atorvastatin (Lipilou)

treatment of dyslipidemia administration : PO, qod

DRUG

Atorvastatin (Lipitor)

treatment of dyslipidemia administration : PO, qod

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY